Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized controlled trial of memantine or lamotrigine added to ongoing mood stabilizer therapy in bipolar I disorder
2013-002055-15Phase 3Active
- Sponsor
- University of Sassari
- Start
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in bipolar I disorder comparing Memantine add-on with Lamotrigine add-on (2 arms). Primary endpoint: Primary endpoints within 52 weeks. Started Sep 2013; status: active.
02
Drugs
memantinelamotrigine
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on 2013-002055-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002055-15.